See more : StateHouse Holdings Inc. (STHZ.CN) Income Statement Analysis – Financial Results
Complete financial analysis of LIWANLI Innovation Co., Ltd. (3054.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LIWANLI Innovation Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Imdex Limited (IMD.AX) Income Statement Analysis – Financial Results
- Huntington Bancshares Incorporated (0J72.L) Income Statement Analysis – Financial Results
- Vtech Holdings Limited (VTKLF) Income Statement Analysis – Financial Results
- Pactiv Evergreen Inc. (PTVE) Income Statement Analysis – Financial Results
- Oxbridge Acquisition Corp. (OXACU) Income Statement Analysis – Financial Results
LIWANLI Innovation Co., Ltd. (3054.TW)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.liwanli.com.tw
About LIWANLI Innovation Co., Ltd.
LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. It provides products in the areas of nutrition and healthcare. The company offers Vigoway and powder collection products for male, female, elderly, and children audience. Its products include probiotic enzymes, pro-active nutrients, resveratrol red grape extract, algae DHA soft gels, shea butter with type II collagen soft gels, algae astaxanthin Q10 soft gels, cordyceps militaries powder, tooth guard tablets, bovine and goat's milk bites, bilberry-tablets, DHA and vitamin D3 drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is based in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 38.89M | 33.99M | 47.81M | 276.88M | 129.78M | 185.51M | 348.21M | 323.10M | 834.91M | 2.24B | 2.44B | 2.74B | 2.32B | 1.02B | 1.24B |
| Cost of Revenue | 23.80M | 22.60M | 40.27M | 301.99M | 127.26M | 174.09M | 399.66M | 285.06M | 832.13M | 2.11B | 2.05B | 2.68B | 2.23B | 981.65M | 1.10B |
| Gross Profit | 15.08M | 11.39M | 7.54M | -25.11M | 2.52M | 11.42M | -51.45M | 38.03M | 2.78M | 123.22M | 392.89M | 55.50M | 85.28M | 37.51M | 144.88M |
| Gross Profit Ratio | 38.79% | 33.52% | 15.77% | -9.07% | 1.94% | 6.16% | -14.77% | 11.77% | 0.33% | 5.51% | 16.08% | 2.03% | 3.68% | 3.68% | 11.65% |
| Research & Development | 10.00K | 87.00K | 174.00K | 4.29M | 17.31M | 25.83M | 32.71M | 29.06M | 34.54M | 21.45M | 19.45M | 14.50M | 12.04M | 11.28M | 13.36M |
| General & Administrative | 21.72M | 18.12M | 19.68M | 20.15M | 17.90M | 17.39M | 34.32M | 29.13M | 43.91M | 64.31M | 87.54M | 64.75M | 63.83M | 49.52M | 43.85M |
| Selling & Marketing | 31.67M | 33.34M | 36.33M | 58.12M | 43.66M | 24.36M | 9.92M | 1.76M | 30.12M | 58.71M | 59.13M | 47.74M | 20.53M | 14.46M | 18.28M |
| SG&A | 53.39M | 51.45M | 56.00M | 78.28M | 61.56M | 41.76M | 44.24M | 30.90M | 74.03M | 123.03M | 146.67M | 112.48M | 84.36M | 63.97M | 62.12M |
| Other Expenses | 0.00 | -80.63M | 105.48M | 90.13M | 89.89M | 60.99M | 222.11M | 94.78M | 27.55M | 46.48M | 112.47M | 14.76M | 15.51M | 19.38M | 14.03M |
| Operating Expenses | 54.87M | 51.54M | 56.18M | 82.57M | 78.87M | 67.58M | 76.95M | 59.96M | 108.57M | 144.47M | 166.12M | 126.98M | 96.40M | 75.25M | 75.48M |
| Cost & Expenses | 78.67M | 74.14M | 96.45M | 384.56M | 206.12M | 241.67M | 476.61M | 345.02M | 940.70M | 2.26B | 2.22B | 2.81B | 2.33B | 1.06B | 1.17B |
| Interest Income | 2.15M | 837.00K | 913.00K | 1.15M | 1.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 473.00K | 2.09M | 1.94M | 1.10M |
| Interest Expense | 582.00K | 313.00K | 512.00K | 1.77M | 212.00K | 296.00K | 409.00K | 8.75M | 9.87M | 9.34M | 4.28M | 2.29M | 1.67M | 201.00K | 29.00K |
| Depreciation & Amortization | 4.26M | 3.08M | 7.51M | 8.87M | 13.16M | 13.97M | 25.84M | 34.95M | 43.35M | 39.05M | 44.13M | 37.39M | 35.38M | 26.38M | 37.77M |
| EBITDA | 6.81M | -116.86M | 65.26M | -3.06M | 29.94M | 20.30M | 119.55M | 107.80M | -38.75M | 62.59M | 383.58M | -24.28M | 36.88M | 165.81M | 113.86M |
| EBITDA Ratio | 17.51% | -335.74% | 136.49% | -1.81% | 23.07% | 12.16% | 35.52% | 34.72% | -4.18% | 2.87% | 15.70% | -0.66% | 2.07% | 1.62% | 9.66% |
| Operating Income | 0.00 | -119.94M | 57.76M | -16.41M | 13.55M | -56.16M | -128.40M | -21.92M | -105.79M | -21.26M | 226.77M | -71.48M | -11.12M | -37.74M | 69.40M |
| Operating Income Ratio | 0.00% | -352.89% | 120.79% | -5.92% | 10.44% | -30.27% | -36.87% | -6.78% | -12.67% | -0.95% | 9.28% | -2.61% | -0.48% | -3.70% | 5.58% |
| Total Other Income/Expenses | 4.72M | -80.11M | 105.88M | 2.70M | 89.68M | 62.20M | 221.70M | 86.03M | 17.68M | 37.15M | 108.40M | 12.33M | 10.95M | 176.97M | 6.67M |
| Income Before Tax | 4.72M | -120.25M | 57.24M | -13.70M | 8.48M | 6.04M | 93.31M | 64.11M | -88.11M | 15.89M | 335.17M | -59.03M | -167.00K | 139.23M | 76.06M |
| Income Before Tax Ratio | 12.14% | -353.81% | 119.72% | -4.95% | 6.53% | 3.26% | 26.80% | 19.84% | -10.55% | 0.71% | 13.72% | -2.16% | -0.01% | 13.66% | 6.12% |
| Income Tax Expense | -382.00K | 655.00K | 11.68M | -91.00K | 5.70M | 5.15M | 11.40M | 1.31M | 15.35M | 585.00K | 45.39M | -882.00K | -35.95M | 21.94M | -10.75M |
| Net Income | 5.10M | -120.91M | 45.56M | -13.61M | 2.78M | 891.00K | 81.91M | 62.80M | -103.45M | 15.30M | 289.78M | -58.15M | 35.78M | 117.29M | 86.82M |
| Net Income Ratio | 13.12% | -355.73% | 95.29% | -4.92% | 2.14% | 0.48% | 23.52% | 19.44% | -12.39% | 0.68% | 11.86% | -2.13% | 1.54% | 11.51% | 6.98% |
| EPS | 0.06 | -1.50 | 0.55 | -0.16 | 0.03 | 0.01 | 0.69 | 0.79 | -1.29 | 0.19 | 3.89 | -1.01 | 0.62 | 2.03 | 1.51 |
| EPS Diluted | 0.06 | -1.50 | 0.55 | -0.16 | 0.03 | 0.01 | 0.69 | 0.78 | -1.29 | 0.19 | 3.83 | -1.01 | 0.62 | 2.02 | 1.51 |
| Weighted Avg Shares Out | 80.65M | 80.65M | 82.63M | 83.41M | 83.41M | 99.88M | 118.18M | 79.37M | 80.10M | 79.39M | 74.63M | 57.50M | 57.69M | 57.69M | 57.69M |
| Weighted Avg Shares Out (Dil) | 80.65M | 80.65M | 82.63M | 83.41M | 83.42M | 99.92M | 118.52M | 91.00M | 80.15M | 79.83M | 75.31M | 57.69M | 57.69M | 57.93M | 57.69M |
Source: https://incomestatements.info
Category: Stock Reports